RJ

Rajesh Jindal

Active Director Managing Director DIN 10514361
DIN 10514361 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Jindal

Data last updated:

Rajesh Jindal is a Managing Director at Mountsan Labs Private Limited (since 2024). The company operates in Pharma.

DIN 10514361
Primary Designation Managing Director
Industry Pharma
First Appointment 19 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mountsan Labs Private Limited U46497DL2024PTC427031
Managing Director19 Feb 20242024Active

Board colleagues of Rajesh Jindal

NameDINCompanyDesignation
Jatin Kumar10514362Mountsan Labs Private LimitedDirector
Nishant Garg09173276Mountsan Labs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mountsan Labs Private Limited
Premium access

Shareholding and investment profile for Rajesh Jindal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Jindal

Rajesh Jindal currently holds 1 directorship: Mountsan Labs Private Limited (Managing Director, since 19 Feb 2024).

Rajesh Jindal was first appointed on 19 Feb 2024 as Managing Director at Mountsan Labs Private Limited.

The current boards of Rajesh Jindal's companies include Jatin Kumar (Mountsan Labs Private Limited), Nishant Garg (Mountsan Labs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available